Cancer drug developer Aktis Oncology said on Wednesday it was targeting a valuation of up to $945.4 million in its upsized ...

The link between the gut and the prostate, known as the 'gut-prostate axis', is becoming increasingly important ...

On the 6th, the Department of Urology at the Catholic University of Korea's Seoul St. Mary's Hospital (Professor Lee Ji-yeol) ...

Investigators reported extended 5-year follow-up data from the CheckMate 274 trial including exploratory MIBC and circulating tumor (ct)DNA data.

Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology ...

There is a significant unmet need for additional treatment options for high-grade NMIBC, especially in those ineligible for BCG.

CHAD Thompson grappled with a silent problem for 20 years – he couldn’t pee properly, and it was a constant source of anxiety ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being over age 55. And the unfortunate reality is that women are often diagnosed at ...

The Environmental Protection Agency (EPA) is set to establish rules to protect industrial workers from a manufacturing gas the agency found may increase cancer risk in certain workplace settings.

Scientists uncovered how childhood BK virus infections may set off cancer-causing mutations decades later: by activating a host immune system enzyme that attacks DNA. When you purchase through links ...